Detalles de la búsqueda
1.
Attenuation of recombinant vesicular stomatitis virus-human immunodeficiency virus type 1 vaccine vectors by gene translocations and g gene truncation reduces neurovirulence and enhances immunogenicity in mice.
J Virol
; 82(1): 207-19, 2008 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-17942549
2.
Vaccination with a HSV-2 UL24 mutant induces a protective immune response in murine and guinea pig vaginal infection models.
Vaccine
; 32(12): 1398-406, 2014 Mar 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-24462481
3.
In vivo biodistribution of a highly attenuated recombinant vesicular stomatitis virus expressing HIV-1 Gag following intramuscular, intranasal, or intravenous inoculation.
Vaccine
; 27(22): 2930-9, 2009 May 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-19428903
4.
Evaluation of neurovirulence and biodistribution of Venezuelan equine encephalitis replicon particles expressing herpes simplex virus type 2 glycoprotein D.
Vaccine
; 25(12): 2296-305, 2007 Mar 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-17239997
5.
Epitope mapping of full-length glycoprotein D from HSV-2 reveals a novel CD4+ CTL epitope located at the transmembrane-cytoplasmic junction.
Cell Immunol
; 239(2): 113-20, 2006 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-16762332
6.
Recombinant vesicular stomatitis virus vectors expressing herpes simplex virus type 2 gD elicit robust CD4+ Th1 immune responses and are protective in mouse and guinea pig models of vaginal challenge.
J Virol
; 80(9): 4447-57, 2006 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-16611905
7.
Herpes simplex virus type 2 UL24 gene is a virulence determinant in murine and guinea pig disease models.
J Virol
; 79(16): 10498-506, 2005 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-16051842
8.
Interleukin-12 redirects murine immune responses to soluble or aluminum phosphate adsorbed HSV-2 glycoprotein D towards Th1 and CD4+ CTL responses.
Vaccine
; 23(2): 236-46, 2004 Nov 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-15531043
Resultados
1 -
8
de 8
1
Próxima >
>>